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A B S T R A C T
This study aimed to present information about the sarsaparilla sold in establishments 
in the state of São Paulo, Brazil, assess the genetic diversity of Smilax brasiliensis Spreng., 
Smilacaceae, and examine the growing conditions and productivity of five species of Smilax. 
The amount of sarsaparilla sold per month at most pharmacies was 0.4 kg on average. 
Herbal stores and markets sold averages of 9 kg and 8 kg per month, respectively. The weight 
of the underground biomass of S. fluminensis (188.3 g) is significantly higher than those of 
other species (28.3-79.6 g). The study demonstrated that high genetic diversity among the 
Smilax brasiliensis plants belonging to the CPQBA germplasm bank, which was confirmed 
by the results of the genotyping study that used a SSR marker on S. brasiliensis. The high 
consumption of sarsaparilla and the low yield of young plants cultivated from seeds with 
high genetic variability reinforce the need for further studies on the production of Smilax 
species.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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Introduction
According to the current Brazilian National Policy on Medicinal 
Plants and Herbal Medicines, investment in research and 
development should be made to meet the demand for raw 
materials for the production of herbal medicines in a safe and 
controlled manner. One problem faced by the Brazilian herbal 
medicine industry is the lack of qualified professionals to meet 
this demand; therefore, collaboration between pharmaceutical 
companies and universities is essential (Calixto, 2003; Marques 
and Petrovick, 2010).
Approximately 25% of therapeutic medicines are of 
plant origin, and 50% are synthetic medicines derived from 
constituents isolated from medicinal plants (Oliveira and Braga, 
2003; Sousa et al., 2008). The increased use of medicinal plants 
in recent decades can be explained by three main factors: a) 
Growing consumer acceptance of plant-based medicines due to 
the feeling, not always justified, that natural products are safer, 
healthier, and more environmentally friendly than synthetic 
products. b) The pharmaceutical industry’s renewed interest 
in finding natural compounds with pharmacological activity 
due to increased consumer acceptance and the lower research 
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and development costs associated with plant-derived products. 
c) Validation from scientific research on commonly used 
plants that have been incorporated into the pharmacopoeia, 
creating the legal conditions necessary for them to be officially 
turned into medicines by pharmacists and to be prescribed by 
physicians (Montanari, 2002).
The Smilacaceae family is distributed in temperate and 
tropical regions of the world, it consists of only the Smilax 
genus (310 species) and in Brazil there are 33 species distributed 
in several ecosystems (Judd et al., 2008; Andreata, 2014). In 
Brazil, medicinal use of Smilax species popularly known as 
“sarsaparilla” dates back to the 16th century (Medeiros et al., 
2007) for their anti-rheumatic, anti-syphilitic (Lorenzi, 2002), 
and diuretic (Schenkel et al., 2010) properties. However, there 
is no information on the commercialization and cultivation of 
these plants in Brazil.
Therefore, this study aimed to present the quantity, value, 
method of preparation, use, and source of the sarsaparilla 
sold in some establishments in the state of São Paulo, Brazil. 
We also aimed to characterize the genetic diversity of Smilax 
brasiliensis and to verify the yield of five species of Smilax (S. 
brasiliensis Spreng., S. campestris Griseb., S. cissoids Mart. ex 
Griseb., S. fluminensis Steud., and S. rufescens Griseb.) after two 
years of culture.
Materials and methods
Interviews in commercial establishments
From December 2010 through May 2011, commercial 
samples of sarsaparilla were obtained, in sealed packages 
or in bulk, from establishments that sell medicinal plants 
(including compounding pharmacies, herbal stores, 
supermarkets, and open markets) in nine medium-to-
large sized cities throughout the state of São Paulo, Brazil: 
Araraquara, Campinas, Piracicaba, Presidente Prudente, 
Registro, Ribeirão Preto, São José dos Campos, São Paulo 
and Sorocaba.
The commercial samples of sarsaparilla were acquired 
from at least three different establishments in each city. A 
total of 44 establishments were visited, including 24 herbal 
stores, ten compounding pharmacies, and ten open markets. 
In eight of the 44 establishments visited, no information 
could be obtained on the source of the samples; therefore, 
36 samples were identified as NSO (Number of Sarsaparilla 
Origination).
Different establishments sold sarsaparilla from the same 
source. In total, we identified twelve different wholesalers 
(Fig. 1), whose identities were kept private so as not to harm 
the interviewees and the establishments visited. 
The person in charge of each commercial establishment 
was questioned about the use of plants, commercial value 
and source of the samples.
The packaging of the samples purchased in the 
pharmacies was labelled with the name, batch, production 
date, expiration date, plant part used, and in some cases, 
botanical identification, such as “Smilax officinalis” or simply 
“Smilax sp”.
Experiment on in-field yield
Seedlings were obtained from the seed germination of Smilax 
brasiliensis Spreng., S. campestris Griseb., S. cissoids Mart. ex 
Griseb., S. fluminensis Steud. and S. rufescens Griseb. in previous 
experiments carried out by our research group (Martins, 2009; 
Soares et al., 2011; Martins et al., 2012). 
When the seedlings reached approximately 15 cm, they were 
transplanted to the experimental field of the Multidisciplinary 
Centre for Chemical, Biological and Agricultural Research 
(CPQBA), University of Campinas, in November 2009. The 
experiment design was of randomised blocks with six 
replications and five plants per plot, with a spacing of 2.5 
m × 1.0 m. The plants were watered as needed, and manual 
weeding was performed to avoid interspecific competition or 
any allelopathic effect. The plants were grown on a trellis and 
staked as they are a climbing species. The plots were harvested 
in April 2012 at the end of the rainy season. The plants were 
subjected to just over two years of cultivation, and the dried 
masses of the aboveground and underground parts of the plant 
were measured. The underground parts and leaves were dried 
at 40°C in a convection gas oven to a constant weight. The 
results were subjected to analysis of variance (ANOVA), and 
treatment means were compared using Tukey’s test at a 5% 
probability level.
DNA extraction
Genomic DNA from the fresh leaves of thirty Smilax brasiliensis 
specimens belonging to the CPQBA germplasm bank was 
extracted using the CTAB (cetyltrimethylammonium 
bromide) protocol described by Doyle and Doyle (1990) with 
modifications according to Martins et al. (2013). The samples 
were subsequently stored at -20°C.
The thirty Smilax brasiliensis specimens provided by the 
CPQBA germplasm bank were obtained at previous germination 
experiments (Martins et al., 2012) based on fruits, sampled 
randomly from individuals of different plant populations in 
Figure 1 - Quantitative representation of the twelve 
sarsaparilla distributors (A-L) regarding the presence of 
the company’s name on the packaging or the number of 
times the distributors were named as wholesalers by the 
commercial establishments visited in the state of São Paulo, 
Brazil.
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the field, ensuring the necessary genetic variability (Martins et 
al., 2012). The Smilax genus is dioecious preventing autogamy 
and increasing genetic variability. 
Microsatellite loci amplification conditions
For the present study, 26 microsatellite markers developed for 
the species S. brasiliensis were tested, and seventeen markers 
were selected for genotyping (Martins et al., 2013).
The amplification products were separated under denaturing 
conditions on 5% (v/v) polyacrylamide gel containing 8 M 
urea and 1X TBE (0.045 M Tris-borate and 0.001 M EDTA) and 
were analysed in an automated sequencer (NEN 4300S DNA 
Analyser-LI-COR Corporate) for approximately 2.5 h at 70 W. 
According to the sequencer operation, the signals emitted after 
the incidence of the laser beam on the different fluorochromes 
present in the primers were captured and converted into an 
electropherogram. Using SAGA-specific computer software, 
the loci were genotyped for further analyses.
Microsatellites
The genetic distance between accession pairs and the dendrogram 
were measured using the Rogers-W distance, and grouping was 
performed according to the UPGMA (unweighted pair-group 
method with arithmetic averaging) criterion using the TFPGA (tools 
for population genetic analysis) software (Miller, 1997). 
Results and discussion
Interviews in commercial establishments
The samples sold in the cities of the inner region of São Paulo 
state, Brazil, came from twelve large herbal stores (Fig. 1), mainly 
located in the state capital. The managers of these herbal stores 
claimed that the material did not originate from cultivation and 
refused to disclose any further information about its origin. 
Knowing the source of an herbal medicine is very important 
for product quality and safety assurance. The exploitation of the 
native flora through extractivism has led to drastic reductions in 
endemic populations because of predatory exploitation and a lack 
of knowledge of preservation mechanisms (Souza et al., 2012). 
Thus, the exploitation of medicinal plants can jeopardise future 
supplies and by mixing them with different plant species result 
in adulteration of the derived products (Lourenzani et al., 2004).
According to the literature, sarsaparilla is indicated for the 
treatment of inflammation (Xu et al., 2005; Shu et al., 2006) and 
rheumatism (Adams et al., 2009). Additionally, it is used as an 
antioxidant (Rugna et al., 2003) and a diuretic (Cáceres et al., 
1987). The establishments that we visited confirmed these uses; 
the most frequently cited use was as a blood cleanser, followed 
by its use as anti-rheumatic and diuretic. In addition to these 
indications, the interviewees added uses as inductor of sweating, 
treatment for syphilis, cholesterol reductor, and as treatment for 
kidney stones, arthritis, acne, uric acid, gout, and poor circulation.
Medeiros et al. (2007) surveyed the indications for 
sarsaparilla treatments proposed by apothecaries in São Bento 
Monastery. They reported essentially the same therapeutic 
applications, as depurative, diuretic, emollient, expectorant, 
anti-leprosy, and sweat inducing. According to the authors, the 
Portuguese also used these plants for the treatment of venereal 
diseases, such as syphilis.
Pereira (2006) conducted another survey on the use and 
knowledge of medicinal plants in the Nova América district 
(Itápolis-SP, Brazil). Of the plants used by the local community, 
sarsaparilla was categorised by the researchers as a plant 
with therapeutic properties for diseases associated with the 
circulatory system. Sarsaparilla was also used as a blood 
cleanser by the interviewees in this community.
Infusion (9%) and decoction (73%) were the most cited 
methods of preparing sarsaparilla in the interviews. According 
to Pereira (2006), these are the most commonly used methods 
because they contribute to hydration, the elimination of toxins, 
and body temperature control. 
In the apothecary shop of the São Bento Monastery, 
decoction was described as the most traditional method for 
preparing sarsaparilla tea. In some recipes for the decoction 
of sarsaparilla, other plants, such as shaved guaiac, shaved 
sassafras, liquorice (Glycyrrhiza glabra L.), and cut flax-leaved 
daphne (Daphne gnidium L.), were included during the decoction 
process (Medeiros et al., 2007).
According to Arnous et al. (2005), who interviewed 376 
people from the city of Dantas (Minas Gerais-MG) on the use 
of medicinal plants, 75.2% of interviewees reported that the 
most popular method of preparation was decoction. According 
to the authors, this finding should be considered with caution 
as only roots, stems, and bark should be boiled because these 
parts have rigid structures. The leaves and flowers, which are 
less fibrous, should not be boiled. 
Rodrigues & Carvalho (2001) interviewed ‘raizeiros’ [herbal 
healers] from rural communities in southern Minas Gerais, 
Brazil, and found that the dosage of the medicinal plant 
must be precise to cure diseases. Excessive doses can cause 
intoxication or  damage. In addition, the duration of use of 
medicinal plants should not be prolonged. In the present 
study the amount of sarsaparilla indicated by commercial 
establishments (Fig. 2) showed that there is no standardization 
of dosage. Although most ethnobotanical surveys do not report 
the amount of plant that should be used for tea preparation, 
these data should be considered for safety.
The average price for 100 g of commercial sarsaparilla was 
U$ 6.00 in pharmacies and U$ 3.00 in herbal stores or markets. 
According to the herbal healers interviewed in the study by 
Rodrigues & Carvalho (2001), the main factor influencing the 
high demand for medicinal plants is the high price of certain 
synthetic medicines. However, we found that the commercial 
cost of sarsaparilla is high and actually exceeds the cost of 
synthetic medicines, including widely commercialised anti-
inflammatory drugs that can be purchased for approximately 
U$ 5.00. Other factors cited by Rodrigues & Carvalho (2001) that 
result in a high demand for sarsaparilla include wellness and 
faster healing by using both synthetic and herbal medicines 
and the side effects caused by synthetic medicines. The 
amount of sarsaparilla sold per month at most pharmacies 
was 0.4 kg on average. Herbal stores and markets sold averages 
of 9 kg and 8 kg per month, respectively. The amount of 
commercialized material is high considering the impact caused 
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by extractivism, since Smilax species are not cultivated in Brazil 
and they have been used in folk medicine since the sixteenth 
century (Medeiros et al., 2007).
its use or importance in televised reports or advertisements. 
This finding was corroborated by Souza et al. (2012), who 
described the media as the primary vehicle for information 
on medicinal plants. However, this information is incomplete 
when it reaches the consumer, resulting in misunderstandings 
about the medicinal use of these plants.
In open markets and herbal stores, the packaging was 
frequently inadequate, without an expiration date or 
botanical identification. According to Bello et al. (2002), the 
standardisation of information on labels and information 
leaflets is needed, as the absence of this information may 
endanger the patient’s health.
Although there is specific legislation for herbal medicine 
in Brazil, it was observed that many products on the market 
do not conform to the law and manufacturers consider 
therapeutic products of herbal origin to be “food” (Amaral et 
al., 2007). 
After labelling verification, the sarsaparilla packages were 
opened and checked for the organic matter. It was observed 
that all samples contained large amounts of foreign organic 
matter, such as unidentified fragments of stems and leaves of 
the same plant or even parts of other plants. A similar study 
was conducted by Leite and Biavatti (1996) and showed that 
39.47% of herbal medicines were contaminated with excessive 
foreign organic matter. This organic matter changed the 
total active ingredient content of the sample. According to 
the authors, this type of contamination may indicate fraud, 
negligence or ignorance by producers and gatherers.
Ocampo et al. (2007) reported that, under management 
conditions, the underground parts of Smilax domingensis in 
Guatemala can be harvested in 4 to 5 years. The average yield 
(fresh weight) of 8-9-year-old plants is 28 kg. These data may 
explain the low dry mass obtained from plants grown in the 
field for only 2 years.
Variation factors Degree of  freedom
Mean square
Underground 
part
Aboveground 
part
g/plant g/plant
Block 5 2,373.2 1,062.5
Species 4 7,420.4a 184,564.8b
Residue 20 2,195.3 5,814.7
Mean 52.7 217.6
Coefficient of 
variation
88.81 35.0
aSignificant at the 5% level using the F-test.  
bSignificant at the 1% level using the F-test.
Table 1
Summary of the analysis of variance, means, and 
experimental coefficients of variation of the aboveground 
and underground parts of five Smilax species. Campinas-SP, 
Brazil. 
Figure 2 - Representation of the amount of sarsaparilla 
indicated for tea preparation.
Experiment on in-field yield
The dry masses of the aboveground and underground parts of 
the plant are shown in Tables 1 and 2. The analysis of variance 
by the F-test showed different yields for the compared species, 
both for the aboveground and the underground plant parts.
The mass of the underground dry matter of Smilax 
fluminensis was significantly higher than those of other species 
with similar masses. S. brasiliensis and S. cissoides had the 
highest aboveground dry masses.
The dry weight of the underground organs of sarsaparilla 
varied between species from 28.3 to 188.3 g (Table 2). Each 
commercialized package of sarsaparilla contains between 30 
and 50 g of dried roots and underground stems. Therefore, it 
can be inferred that approximately one to two native Brazilian 
plants are harvested for each package suggesting that the level of 
extractivism is very high. This degree of extractivism may hinder 
the survival and conservation of these species in the Brazilian 
flora.
Soares et al. (2011) reported that the capacity of Smilax 
fluminensis to propagate from seeds and cuttings confirms 
its potential for sustainable economic use. This propagation 
would be an alternative to reduce the predatory extractivism of 
this native species. However, Martins et al. (2011; 2012) showed 
that, in contrast to S. fluminensis, the germination rates of other 
Brazilian species of Smilax are low. According to the authors, 
the germination of the genus Smilax is complex; the seeds 
require a long time to germinate, and seedling development 
is slow. They also reported that there are no studies on large-
scale cultivation of this genus in Brazil and the product 
marketed as sarsaparilla originates from extractivism.
According to the merchants interviewed in our study, the 
demand for sarsaparilla increases if there is any mention of 
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Microsatellites
A higher than desirable coefficient of variation for a cultivation 
experiment can be attributed to high genetic diversity among 
plants obtained by sexual propagation and produced from 
seeds collected under natural conditions.  Diversity was 
confirmed by the results of the genotyping study, which used 
a simple sequence repeat (SSR) marker in Smilax brasiliensis. 
The genetic variability of the germplasm bank of S. brasiliensis 
can be observed in the dendrogram obtained by the UPGMA 
grouping method using Roger’s genetic distance matrix, 
modified by Wright (Fig. 3). The germplasm bank displayed 
wide diversity, with 1 and 2 being the closest individuals. 
Analysing the dendrogram, it is possible to visualise two 
groups at a distance of 0.90. These groups included individuals 
17 and 30 (group I), the most distant from the others, and the 
remainder of the individuals (group II). Group II displayed a 
large genetic variation according to microsatellite markers. 
Numerous divisions were observed in group II; however, 
genotypes 3, 6, 15, and 27 were differentiated from the others 
at a distance of 0.70.
Groups showed in the dendrogram are important to 
characterize the genetic diversity of one of most important 
sarsaparilla species. These approaches will lead to a better 
understanding of genetic variation on this medicinal plant and 
to the management support of germplasm collections.
Some studies have indicated the need to establish 
germplasm banks of medicinal species to preserve their 
genetic diversity, especially those that, similar to sarsaparilla, 
are subject to high extractivism in Brazil. Skorupa and Assis 
(1998) reported that Psychotria ipecacuanha, Rubiaceae, has been 
extensively exploited throughout Brazil for decades due to the 
medicinal properties attributed to its roots. Biondo et al. (2007) 
studied the medicinal plant Mandevilla velutina, Apocynaceae, 
native of the Brazilian ‘Cerrado’ (tropical savannah) and has 
anti-ophidian properties.
Our study demonstrated the high genetic diversity among 
Smilax brasiliensis plants belonging to the CPQBA germplasm 
bank. Genetic diversity facilitates plant breeding, and 
knowledge of germplasm diversity exerts a significant impact 
on the cultivated plants improvement (Huang et al., 2002). 
According to Belaj et al. (2002), knowledge of genetic diversity 
among olive tree (Olea europaea) cultivars through random 
amplified polymorphic DNA (RAPD) techniques maximises the 
long-term use of genetic resources in breeding programs, given 
the genetic variability among the cultivars. In addition to RAPD 
techniques, microsatellite markers can also be used to detect 
genetic diversity, as discussed by Huang et al. (2002), who 
analysed wheat (Triticum aestivum) from germplasm banks.
In conclusion, the high volume of sarsaparilla consumption, 
the low yield of young plants cultivated from seeds, and the 
high genetic variability of plants originating from sexual 
propagation observed in Smilax brasiliensis reinforce the need 
for further studies on the production of Smilax species in Brazil.
Plant part
Species
S. brasiliensis S. campestris S. fluminensis S. rufescens S.  
cissoides
Underground 59.7b 59.7b 188.3a 28.3b 79.6b
Aboveground 425.4a 122.4b 124.2b 21.0b 394.6a
Table 2
Mean dry masses (g/plant) of the aboveground and underground parts of Smilax species. Campinas-SP, Brazil. Means followed 
by different letters in the same row indicate significance at 5% using Tukey’s test.
Figure 3 - Pattern of genetic divergence among the Smilax 
brasiliensis population present in the CPQBA germplasm bank 
in Campinas-SP, Brazil, by UPGMA clustering, based on the 
genetic identity obtained using Rogers-W genetic distance. 
The cophenetic correlation was 0.876.
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